MediPharm Labs (STU:MLZ) Accounts Payable & Accrued Expense : €4.45 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is MediPharm Labs Accounts Payable & Accrued Expense?

MediPharm Labs's quarterly accounts payable & accrued expense declined from Sep. 2023 (€4.35 Mil) to Dec. 2023 (€3.78 Mil) but then increased from Dec. 2023 (€3.78 Mil) to Mar. 2024 (€4.45 Mil).

MediPharm Labs's annual accounts payable & accrued expense increased from Dec. 2021 (€3.38 Mil) to Dec. 2022 (€4.03 Mil) but then declined from Dec. 2022 (€4.03 Mil) to Dec. 2023 (€3.78 Mil).

MediPharm Labs Accounts Payable & Accrued Expense Historical Data

The historical data trend for MediPharm Labs's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediPharm Labs Accounts Payable & Accrued Expense Chart

MediPharm Labs Annual Data

Trend

Sep17

Sep18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

17.55

9.04

3.38

4.03

3.78

MediPharm Labs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															3.44	5.70	4.35	3.78	4.45

MediPharm Labs Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

MediPharm Labs (STU:MLZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (STU:MLZ) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

MEDIF:USA MLZ:Germany LABS:Canada

Address

151 John Street, Barrie, ON, CAN, L4N 2L1

Website

https://www.medipharmlabs.com

MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis extracts and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.

MediPharm Labs (STU:MLZ) Headlines

No Headlines